Cargando…

A longitudinal clinical and MRI evaluation of the treatment with erenumab

Detalles Bibliográficos
Autores principales:	Coccia, Alberto, Lapucci, Caterina, di Poggio, Monica Bandettini, Grazzini, Matteo, Inglese, Matilde, Finocchi, Cinzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448403/ https://www.ncbi.nlm.nih.gov/pubmed/32845491 http://dx.doi.org/10.1007/s10072-020-04660-7

Ejemplares similares

Request of hospital care dropped for TIA but remained stable for stroke during COVID-19 pandemic at a large Italian university hospital
por: Balestrino, Maurizio, et al.
Publicado: (2020)

Successful treatment of primary headache associated with sexual activity using erenumab: Case report
por: Makarevičius, Gytis, et al.
Publicado: (2022)

The role of disconnection in explaining disability in multiple sclerosis
por: Lapucci, Caterina, et al.
Publicado: (2022)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men
por: Ornello, Raffaele, et al.
Publicado: (2021)

Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials
por: Di Tanna, Gian Luca, et al.
Publicado: (2019)

Different MRI patterns in MS worsening after stopping fingolimod
por: Lapucci, Caterina, et al.
Publicado: (2019)

Longitudinal advanced MRI case report of white matter radiation necrosis
por: Wiggermann, Vanessa, et al.
Publicado: (2018)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Mapping tissue microstructure across the human brain on a clinical scanner with soma and neurite density image metrics
por: Schiavi, Simona, et al.
Publicado: (2023)

Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study
por: Diener, Hans-Christoph, et al.
Publicado: (2021)

Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities
por: Lapucci, Caterina, et al.
Publicado: (2023)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Lichenoid drug eruption induced by erenumab
por: Musicante, Meryl, et al.
Publicado: (2022)

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
por: Bauckneht, Matteo, et al.
Publicado: (2019)

Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab
por: Schwedt, Todd J., et al.
Publicado: (2022)

Longitudinal follow-up of postacute COVID-19 syndrome: DL(CO), quality-of-life and MRI pulmonary gas-exchange abnormalities
por: Matheson, Alexander M, et al.
Publicado: (2023)

Improved detection of multiple sclerosis lesions with T2‐prepared double inversion recovery at 3T
por: Costagli, Mauro, et al.
Publicado: (2022)

Assessment and characteristics of Erenumab therapy on migraine management
por: Saeed, Haitham, et al.
Publicado: (2022)

Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy
por: Gaur, Lasya, et al.
Publicado: (2016)

The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
por: Filippi, Massimo, et al.
Publicado: (2023)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
por: Sbragia, Elvira, et al.
Publicado: (2022)

Predictors of response to erenumab after 12 months of treatment
por: Baraldi, Carlo, et al.
Publicado: (2021)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

Myocardial infarction associated with erenumab: A case report
por: Perino, Justine, et al.
Publicado: (2022)

Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India
por: Chowdhury, Debashish, et al.
Publicado: (2022)

Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023)

Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
por: Silvestro, Marcello, et al.
Publicado: (2021)

Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine
por: Nikolova, Simona, et al.
Publicado: (2023)

Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS
por: Harel, Asaff, et al.
Publicado: (2016)

Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice
por: Bruschi, Nicolo’, et al.
Publicado: (2020)

Kallmann syndrome: MRI findings
por: Zaghouani, Houneida, et al.
Publicado: (2013)

Impact of COVID-19 on chronic migraine treated with erenumab: a case report
por: Grassini, Alberto, et al.
Publicado: (2021)

Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS
por: Cellerino, Maria, et al.
Publicado: (2019)

Efficacy and safety of erenumab in women with a history of menstrual migraine
por: Pavlovic, Jelena M., et al.
Publicado: (2020)

Early onset of efficacy with erenumab in patients with episodic and chronic migraine
por: Schwedt, Todd, et al.
Publicado: (2018)

Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
por: Manickam, Agaath Hedina, et al.
Publicado: (2021)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32l56hh7leptgj2bgdqp48qm0q